Notícias Eulerpool Neurosense Therapeutics

Neurosense Therapeutics Eulerpool-AFX

Neurosense Therapeutics Notícias de ações

Neurosense Therapeutics é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Neurosense Therapeutics nós reunimos aqui.

• 16 de agosto ·

  TipRanks
  NeuroSense Therapeutics Announces Share Issuance
• 7 de agosto ·

  Yahoo
  NeuroSense Therapeutics Announces Private Placement with Senior Management Participation at Premium to Market Price
• 7 de agosto ·

  TipRanks
  NeuroSense Therapeutics Announces Strategic Securities Sale
• 1 de agosto ·

  Yahoo
  NeuroSense Therapeutics Announces Positive Biomarker Data from ALS Phase 2b Clinical Trial
• 1 de agosto ·

  TipRanks
  NeuroSense’s ALS Drug Shows Promise in Trial
• 1 de agosto ·

  Thefly.com
  NeuroSense's PrimeC shows positive biomarker data from ALS Phase 2b trial
• 9 de julho ·

  Yahoo
  NeuroSense's PARADIGM ALS Clinical Trial Demonstrates Up to 73% Improved Complication-Free Survival Following Statistically Significant Slowing of Disease Progression
• 1 de julho ·

  Yahoo
  NeuroSense Demonstrates Statistically Significant Efficacy and Survival Benefits in People Living with ALS: The Promising Results from the 12-Month PARADIGM Study Highlight PrimeC's Potential as a Disease Modifying Drug
• 27 de junho ·

  TipRanks
  NeuroSense Extends Warrant Termination, Revises Terms
• 24 de junho ·

  Yahoo
  NeuroSense Management Provides Corporate Update and First Quarter 2024 Financial Results